Schizophrenia Research
Volume 100, Issue 1 , Pages 342-348 , March 2008

Validation of a Clinical Global Impression Scale for Aggression (CGI-A) in a sample of 558 psychiatric patients

  • Christian G. Huber

      Affiliations

    • Psychosis Early Detection and Intervention Centre (PEDIC), Centre for Psychosocial Medicine, Department of Psychiatry and Psychotherapy, University Medical Centre Hamburg-Eppendorf, Germany
    • ,
  • Martin Lambert

      Affiliations

    • Psychosis Early Detection and Intervention Centre (PEDIC), Centre for Psychosocial Medicine, Department of Psychiatry and Psychotherapy, University Medical Centre Hamburg-Eppendorf, Germany
    • Corresponding Author InformationCorresponding author. Psychosis Early Detection and Intervention Centre (PEDIC), Centre for Psychosocial Medicine, Department of Psychiatry and Psychotherapy, University Medical Centre Hamburg-Eppendorf, Martinistr. 52, D-20246 Hamburg, Germany. Tel.: +49 40 42803 7670; fax: +49 40 42803 5455.
    • ,
  • Dieter Naber

      Affiliations

    • Psychosis Early Detection and Intervention Centre (PEDIC), Centre for Psychosocial Medicine, Department of Psychiatry and Psychotherapy, University Medical Centre Hamburg-Eppendorf, Germany
    • ,
  • Alexander Schacht

      Affiliations

    • Medical Neuroscience Department, Lilly Deutschland GmbH, Germany
    • ,
  • Hans-Peter Hundemer

      Affiliations

    • Medical Neuroscience Department, Lilly Deutschland GmbH, Germany
    • ,
  • Thomas T. Wagner

      Affiliations

    • Medical Neuroscience Department, Lilly Deutschland GmbH, Germany
    • ,
  • Benno G. Schimmelmann

      Affiliations

    • Department of Child and Adolescent Psychiatry, University Duisburg-Essen, Germany

Received 13 October 2007 ,Revised 15 December 2007 ,Accepted 20 December 2007.

References 

  1. Allen MH, Currier GW, Hughes DH, Reyes-Harde M, Docherty JP. The expert consensus guideline series. In: Postgraduate medicine. 2001;p. 1–88
  2. Allen MH, Currier GW, Carpenter D, Ross RW, Docherty JP. Treatment of behavioral emergencies 2005. J. Psychiatr. Pract. 2005;11(Suppl 1):5–108
  3. Baker RW, Kinon BJ, Maguire GA, Liu H, Hill AL. Effectiveness of rapid initial dose escalation of up to forty milligrams per day of oral olanzapine in acute agitation. J. Clin. Psychopharmacol. 2003;23:342–348
  4. Barzman DH, DelBello MP, Adler CM, Stanford KE, Strakowski SM. The efficacy and tolerability of quetiapine versus divalproex for the treatment of impulsivity and reactive aggression in adolescents with co-occurring bipolar disorder and disruptive behavior disorder(s). J. Child Adolesc. Psychopharmacol. 2006;16:665–670
  5. Breier A, Meehan K, Birkett M, David S, Ferchland I, Sutton V, et al. A double-blind, placebo-controlled dose–response comparison of intramuscular olanzapine and haloperidol in the treatment of acute agitation in schizophrenia. Arch Gen Psychiatry. 2002;59:441–448
  6. Currier GW, Chou JC, Feifel D, Bossie CA, Turkoz I, Mahmoud RA, et al. Acute treatment of psychotic agitation: a randomized comparison of oral treatment with risperidone and lorazepam versus intramuscular treatment with haloperidol and lorazepam. J. Clin. Psychiatry. 2004;65:386–394
  7. Currier GW, Trenton AJ, Walsh PG, van Wijngaarden E. A pilot, open-label safety study of quetiapine for treatment of moderate psychotic agitation in the emergency setting. J. Psychiatr. Pract. 2006;12:223–228
  8. Frazier JA, Meyer MC, Biederman J, Wozniak J, Wilens TE, Spencer TJ, et al. Risperidone treatment for juvenile bipolar disorder: a retrospective chart review. J. Am. Acad. Child Adolesc. Psych. 1999;38:960–965
  9. Guy W. Clinical global impression. ECDEU Assessment Manual for Psychopharmacology, revised. In: Guy, W. Rockville, MI, National Insitute of Mental Health. 1976;p. 217–222
  10. Haro JM, Kamath SA, Ochoa S, Novick D, Rele K, Fargas A, et al. The Clinical Global Impression-Schizophrenia scale: a simple instrument to measure the diversity of symptoms present in schizophrenia. Acta Psychiatr. Scand. 2003;16–23Suppl
  11. Haro JM, Ochoa S, Gervin M, Mavreas V, Jones P. Assessment of remission in schizophrenia with the CGI and CGI-SCH scales. Acta Psychiatr. Scand. 2007;115:163–164author reply 164
  12. Kay SR, Sevy S. Pyramidical model of schizophrenia. Schizophr. Bull. 1990;16:537–545
  13. Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr. Bull. 1987;13:261–276
  14. Leucht S, Kane JM, Kissling W, Hamann J, Etschel E, Engel R. Clinical implications of Brief Psychiatric Rating Scale scores. Br. J. Psychiatry. 2005;187:366–371
  15. Leucht S, Kane JM, Kissling W, Hamann J, Etschel E, Engel RR. What does the PANSS mean?. Schizophr. Res. 2005;79:231–238
  16. Leucht S, Kane JM, Etschel E, Kissling W, Hamann J, Engel RR. Linking the PANSS, BPRS, and CGI: clinical implications. Neuropsychopharmacology. 2006;31:2318–2325
  17. Lindenmayer JP. The pathophysiology of agitation. J. Clin. Psychiatry. 2000;61(Suppl 14):5–10
  18. Lindenmayer JP, Czobor P, Alphs L, Nathan AM, Anand R, Islam Z, et al. The InterSePT scale for suicidal thinking reliability and validity. Schizophr. Res. 2003;63:161–170
  19. MacMillan CM, Korndorfer SR, Rao S, Fleisher CA, Mezzacappa E, Gonzalez-Heydrich J. A comparison of divalproex and oxcarbazepine in aggressive youth with bipolar disorder. J. Psychiatr. Pract. 2006;12:214–222
  20. Meehan KM, Wang H, David SR, Nisivoccia JR, Jones B, Beasley CM, et al. Comparison of rapidly acting intramuscular olanzapine, lorazepam, and placebo: a double-blind, randomized study in acutely agitated patients with dementia. Neuropsychopharmacology. 2002;26:494–504
  21. Pascual JC, Madre M, Puigdemont D, Oller S, Corripio I, Diaz A, et al. A naturalistic study: 100 consecutive episodes of acute agitation in a psychiatric emergency department. Actas Esp. Psiquiatr. 2006;34:239–244
  22. Pascual J, Perez V, Martin J, Safont G, Puigdemont D, Alvarez E. Olanzapine orally-disintegrating tablet in severe psychotic agitation: a naturalistic study. Actas Esp. Psiquiatr. 2007;35:47–51
  23. Salzmann E, Robin JL. Multicentric double-blind study comparing efficacy and safety of minaprine and imipramine in dysthymic disorders. Neuropsychobiology. 1995;31:68–75
  24. San L, Arranz B, Querejeta I, Barrio S, De la Gandara J, Perez V. A naturalistic multicenter study of intramuscular olanzapine in the treatment of acutely agitated manic or schizophrenic patients. Eur. Psychiatr. 2006;21:539–543
  25. Sharif ZA, Raza A, Ratakonda SS. Comparative efficacy of risperidone and clozapine in the treatment of patients with refractory schizophrenia or schizoaffective disorder: a retrospective analysis. J. Clin. Psychiatry. 2000;61:498–504
  26. Sival RC, Duivenvoorden HJ, Jansen PA, Haffmans PM, Duursma SA, Eikelenboom P. Sodium valproate in aggressive behaviour in dementia: a twelve-week open label follow-up study. Int. J. Geriatr. Psychiatry. 2004;19:305–312
  27. Spearing MK, Post RM, Leverich GS, Brandt D, Nolen W. Modification of the Clinical Global Impressions (CGI) Scale for use in bipolar illness (BP): the CGI-BP. Psychiatry Res. 1997;73:159–171
  28. Turczynski J, Bidzan L, Staszewska-Malys E. Olanzapine in the treatment of agitation in hospitalized patients with schizophrenia and schizoaffective and schizofreniform disorders. Med. Sci. Monit. 2004;10:PI74–PI80
  29. WHO . ICD-10: The ICD-10 Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines. Geneva: World Health Organisation (WHO); 1992;
  30. Wright P, Meehan K, Birkett M, Lindborg SR, Taylor CC, Morris P, et al. A comparison of the efficacy and safety of olanzapine versus haloperidol during transition from intramuscular to oral therapy. Clin. Ther. 2003;25:1420–1428
  31. Zhong KX, Tariot PN, Mintzer J, Minkwitz MC, Devine NA. Quetiapine to treat agitation in dementia: a randomized, double-blind, placebo-controlled study. Curr. Alzheimer Res. 2007;4:81–93

PII: S0920-9964(08)00040-6

doi: 10.1016/j.schres.2007.12.480

Schizophrenia Research
Volume 100, Issue 1 , Pages 342-348 , March 2008

Article Tools

* Image Usage & Resolution